Search for: "Small v. Goldman" Results 261 - 280 of 331
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Aug 2016, 10:30 am by Rebecca Tushnet
  Also, consider Brownmark v. [read post]
6 Aug 2014, 8:11 am by Eric Goldman
Last year, I added an optional midterm with a small grading bonus for those who chose to do it. [read post]
22 Apr 2011, 9:21 am by RT
Likely to be true only in a vanishingly small set of cases. [read post]
30 Jun 2023, 5:48 am by Rebecca Tushnet
Raise the costs of the industry, rewarding big and punishing small, so we’ll see a shrinking number of players who offer UGC as a matter of economics. [read post]
19 Mar 2019, 7:24 am by Katherine Kelley
In a small number of cases in this sample, perpetrators appear to be sextorting for a goal that is neither sexual nor financial in nature; the Bezos case is a high-profile example of this sort of activity. [read post]
17 Feb 2015, 5:00 am by Ron Coleman
”  Deborah notes that, in fact, the recognition of trademark rights in retail store layouts was recognized by the Supreme Court in Two Pesos v. [read post]
18 Apr 2010, 10:01 am by Rebecca Tushnet
This is bound up with rules v. standards. [read post]
23 Feb 2024, 1:43 pm by Rebecca Tushnet
., is using his father’s famous name to promote himself politically (also highlighting the importance of small differences when it comes to speech in the political realm). [read post]
7 May 2018, 1:51 pm by Rebecca Tushnet
We may not be representative of different companies b/c we are small & receive a small number of requests that vary in what they ask for—readership over a period of time v. individual info. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real… [read post]